On the other hand, there can be small neoplastic clones that not only may have a different HER2 status from the majority of the primary cancer cells, but also may have enhanced potential to metastasize, leading to metastases of clones with discordant HER2 genes from the primary tumor [34], [35]. The gene discussed is ERBB2; the disease is neoplasm.